MLchartDataset catalogue

FLT3 inhibitor XY0206

Term · Oncology and biomedicine · MLC-T-ONC-013629

A selective inhibitor of FMS-like tyrosine kinase 3 (FLT3; CD135; STK1; FLK2) with potential antineoplastic activity. Upon administration, FLT3 inhibitor XY0206 targets, binds to and inhibits the activity of FLT3. This inhibits the proliferation of FLT3-expressing cancer cells. FLT3, a class III receptor tyrosine kinase (RTK), is overexpressed or mutated in most B-lineage neoplasms and in acute myeloid leukemias.

Table 1. Record
IdentifierMLC-T-ONC-013629
FieldOncology and biomedicine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-013629",
  "term": "FLT3 inhibitor XY0206",
  "field": "Oncology and biomedicine",
  "definition": "A selective inhibitor of FMS-like tyrosine kinase 3 (FLT3; CD135; STK1; FLK2) with potential antineoplastic activity. Upon administration, FLT3 inhibitor XY0206 targets, binds to and inhibits the activity of FLT3. This inhibits the proliferation of FLT3-expressing cancer cells. FLT3, a class III receptor tyrosine kinase (RTK), is overexpressed or mutated in most B-lineage neoplasms and in acute myeloid leukemias.",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/flt3-inhibitor-xy0206/"
}

Record 7,363 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.